Terran Biosciences

2:00 PM - 2:15 PM (EDT), Tuesday, October 22, 2019 ・ 2nd Floor
Terran is a clinical stage biotech company developing therapeutics and diagnostics to change the lives of patients with neurological and psychiatric diseases. We have a phase 3 ready asset, multiple preclinical assets, and two complementary technologies that enable smart trials, increasing our probability of clinical and regulatory success:

1) Novel imaging device to measure clinically validated biomarkers
2) Best-in-class cerebral organoid precision medicine platform

Both technologies will also be independently commercialized to generate near-term revenue and de-risk future development, with initial product launch planned for 2020 in a multi-billion dollar accessible market.

We have an all-star leadership team on board with over 20 successful FDA approvals (including Abilify and Serzone), an experienced commercial launch team, and blue-chip early investors, including Peter Thiel, Christian Angermayer, and Presight Capital.
Company Type:
Company Website:
Company HQ State:
New York
Company HQ Country:
United States
Year Founded:
2017
Main Therapeutic Focus:
Lead Product in Development:
Imaging device platform
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided